This intricate interplay underscores the pivotal roles of ICAM-1 and VCAM-1 in cardiovascular pathophysiology and accentuates their potential as therapeutic targets for mitigating cardiovascular disease progression, particularly through the modulation of NF-kB signaling [46]. This evidence concerns the gene VCAM1 and cardiovascular disorder.